Evidence map›Paper›PMID 41439122›Full record

ArticleAlzheimer's & dementia (New York, N. Y.)

Protocol for the Asian Cohort for Alzheimer's Disease (ACAD) Study.

Pei-Chuan Ho, Guerry M Peavy, Haeok Lee, Yian Gu, Walter A Kukull, Yun-Beom Choi, Wai Haung Yu, Dolly Reyes-Dumeyer, Victor W Henderson, Boon Lead Tee and 14 more

Abstract read
In one paragraph

Article in Alzheimer's & dementia (New York, N. Y.). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Pei-Chuan HoDepartment of Pathology and Laboratory Medicine Penn Neurodegeneration Genomics Center Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA.
Guerry M PeavyDepartment of Neurosciences University of California San Diego La Jolla California USA.
Haeok LeeMeyers College of Nursing New York University New York New York USA.
Yian GuDepartments of Neurology and Epidemiology the Sergievsky Center and the Taub Institute Columbia University Irving Medical Center New York New York USA.
Walter A KukullDepartment of Neurology Washington University St. Louis St. Louis Missouri USA.
Yun-Beom ChoiEnglewood Health Englewood New Jersey USA.
Wai Haung YuDepartment of Pharmacology and Toxicology University of Toronto Toronto Ontario Canada.
Dolly Reyes-DumeyerDepartments of Neurology and Epidemiology the Sergievsky Center and the Taub Institute Columbia University Irving Medical Center New York New York USA.
Victor W HendersonDepartment of Epidemiology and Population Health Stanford University Stanford California USA.
Boon Lead TeeMemory and Aging Center University of California at San Francisco San Francisco California USA.
Howard H FeldmanDepartment of Neurosciences University of California San Diego La Jolla California USA.
Clara LiDepartment of Psychiatry Icahn School of Medicine at Mount Sinai New York New York USA.
Hyun-Sik YangDepartment of Neurology Center for Alzheimer Research and Treatment Brigham and Women's Hospital Boston Massachusetts USA.
Jody-Lynn LupoAlzheimer's Disease Cooperative Study University of California La Jolla California USA.
Ging-Yuek R HsiungDivision of Neurology, University of British Columbia, Vanada Vancouver BC Canada.
Collin LiuDepartment of Neurology Keck School of Medicine at University of Southern California Los Angeles California USA.
Ellen C WongDepartment of Neurology Keck School of Medicine at University of Southern California Los Angeles California USA.
Richard MayeuxDepartments of Neurology and Epidemiology the Sergievsky Center and the Taub Institute Columbia University Irving Medical Center New York New York USA.
Asian Cohort for Alzheimer's Disease Study
Van M Ta ParkDepartment of Community Health Systems School of Nursing University of California San Francisco California USA.
Gyungah R JunDepartment of Medicine (Biomedical Genetics) Boston University School of Medicine Boston Massachusetts USA.
Helena C ChuiDepartment of Neurology Keck School of Medicine at University of Southern California Los Angeles California USA.
Li-San WangDepartment of Pathology and Laboratory Medicine Penn Neurodegeneration Genomics Center Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA.
Tiffany W ChowDepartment of Pathology and Laboratory Medicine Penn Neurodegeneration Genomics Center Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA.ORCID https://orcid.org/0009-0001-1324-2872

Funding

USCADRC Diversity Supplement PachicanoP30AG066530 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI HELENA Chang CHUI · 2020 to 2026
$27.8M
Chinese language versions of the National Alzheimer's Coordinating Center's Uniform Data Set version 4: a linguistic and cultural adaptation studyR01AG083840 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Clara Li, Boon Lead Tee · 2023 to 2026
$5.3M
The impact of bilingualism on cognitive reserve/resilience using socio-demographically and linguistically diverse populationsR01AG080469 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Suvarna Alladi, Ganesh M Babulal · 2023 to 2026
$4.0M
NIA NIH HHS P30 AG066530NIA NIH HHS R01 AG080469NIA NIH HHS R01 AG083840
6 · The paper itself

Abstract

introductionTo address knowledge gaps in Alzheimer's disease (AD) research, the Asian Cohort for Alzheimer's Disease (ACAD) Study will recruit over 5000 participants of Asian descent aged 60 or older in the United States and Canada. The current focus is on participants with Chinese, Korean, or Vietnamese ancestry, with the goal of characterizing both genetic and non-genetic risk factors. ACAD has assembled a culturally and linguistically appropriate data collection protocol, as well as a biosample collection protocol. Recruitment strategies follow community-based participatory research (CBPR) approaches to encourage research participation and engage Asian communities in brain health education.

methodsThe ACAD Clinical Core has developed a data collection packet (DCP) that gathers information on demographics, lifestyle factors, medical history, functional impairment, and cognitive status to support a dementia-related consensus diagnosis. Questionnaires and cognitive tests in the DCP are carefully selected or adapted to strike balance between alignment with existing AD cohorts and capturing the uniqueness in Asian subpopulations that may be related to AD. ACAD conducts a 2-year follow-up visit with all participants and a second 2-year follow-up visit with those participants who received a diagnosis of mild cognitive impairment at the first follow-up visit to confirm the robustness of the DCP and capture the trajectory of cognitive decline. DISCUSSION: ACAD is well positioned to address major challenges in recruitment, language barriers, and cultural appropriateness to ensure accurate assessment with the use of the DCP (developed in ACAD targeted languages) and multilingual research coordinators. Along with DNA and plasma biomarkers derived from biosamples, ACAD integrates comprehensive survey and cognitive data to facilitate multidimensional analyses. The data collection protocol is adaptable for other Asian subpopulations beyond ACAD's current focus, with an expectation of further bridging the gap in participant diversity within AD research. Highlights: Asian Americans and Asian Canadians constitute one of the fastest growing non-White older populations.Asians have been under-represented in American and Canadian AD research.The ACAD Study addresses that under-representation in research.The study investigates Chinese, Vietnamese, and Korean genetic and non-genetic risk factors for AD.The data collection protocol is adapted for Asians but maintains synergy with existing cohorts.

Indexed as

Alzheimer's diseaseAsianbiomarkerChinesecognitive testconsensusdementiadiagnosisevaluationgeneticsKoreanmild cognitive impairmentremote assessmentsubjective cognitive complaintVietnamese

Identifiers

PMID41439122
PMCPMC12720140

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.